Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology

被引:33
作者
Huang, YB [1 ]
Tsai, YH [1 ]
Yang, WC [1 ]
Chang, JS [1 ]
Wu, PC [1 ]
机构
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung 80708, Taiwan
关键词
propranolol; hydroxypropylmethyleellulose (HPMC); dissolution test; response surface methodology;
D O I
10.1248/bpb.27.1626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to develop propranolol extended release formulations containing hydroxypropylmethylcellulose (HPMC). The results indicate that the drug release from the tablet form containing a high amount of HPMC was incomplete, and avicel addition could increase the release percent at a later stage. In order to readily obtain an optimal formulation, response surface methodology and multiple response optimization utilizing a quadratic polynomial equation was used. The model formulations were prepared according to a factorial design. The effects of causal factors including the HPMC/drug ratio (X-1) and avicel level (X-2), on drug release were also measured. The drug release percentage at 1.5, 4, 8, 14 and 24 It were the target response and were restricted to not more than 25%, 35-50%, 55-70%, 75-90%, and 95-110%, respectively. The results showed that the optimized formulation provided a dissolution pattern equivalent to the predicted curve, which indicated that the optimal formulation could be obtained using response surface methodology. The mechanism of drug release from HMPC matrices tablets followed quasi-Fickian diffusion.
引用
收藏
页码:1626 / 1629
页数:4
相关论文
共 24 条
[1]   Optimization of a granulation procedure for a hydrophilic matrix tablet using experimental design [J].
Bouckaert, S ;
Massart, DL ;
Massart, B ;
Remon, JP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (04) :321-327
[2]   DOG AS A QUANTITATIVE MODEL FOR EVALUATION OF NONDISINTEGRATING SUSTAINED-RELEASE TABLETS [J].
CRESSMAN, WA ;
SUMNER, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (01) :132-&
[3]  
Eddington N D, 1998, Pharm Dev Technol, V3, P535, DOI 10.3109/10837459809028636
[4]  
EFENTAKIS M, 1990, ACTA PHARM TECHNOL, V36, P237
[5]  
FDA U., 1997, GUID IND DISS TEST I
[6]   INFLUENCE OF SURFACTANTS ON DRUG RELEASE FROM HYDROXYPROPYLMETHYLCELLULOSE MATRICES [J].
FEELY, LC ;
DAVIS, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 41 (1-2) :83-90
[7]   MATHEMATICAL-MODELING OF DRUG RELEASE FROM HYDROXYPROPYLMETHYLCELLULOSE MATRICES - EFFECT OF TEMPERATURE [J].
FORD, JL ;
MITCHELL, K ;
ROWE, P ;
ARMSTRONG, DJ ;
ELLIOTT, PNC ;
ROSTRON, C ;
HOGAN, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 71 (1-2) :95-104
[8]   FORMULATION OF SUSTAINED-RELEASE PROMETHAZINE HYDROCHLORIDE TABLETS USING HYDROXYPROPYLMETHYLCELLULOSE MATRICES [J].
FORD, JL ;
RUBINSTEIN, MH ;
HOGAN, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 24 (2-3) :327-338
[9]   Swelling of hydroxypropyl methylcellulose matrix tablets .1. Characterization of swelling using a novel optical imaging method [J].
Gao, P ;
Meury, RH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :725-731
[10]   Formulation optimization of controlled release diclofenac sodium microspheres using factorial design [J].
Gohel, MC ;
Amin, AF .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :115-122